The National Pharmaceutical Regulatory Agency (NPRA), Malaysia, issued a communication on 10 June 2026 regarding the renewal approval of veterinary products. The publication appears to provide information on Veterinary Products that have successfully undergone the Renewal Approval process and continue to hold valid Market Authorization status in Malaysia.
The renewal process is an essential regulatory mechanism that ensures Veterinary Medicines continue to meet established standards of quality, safety, and efficacy throughout their lifecycle. The communication highlights the importance of maintaining valid Product Registration through timely renewal submissions and adherence to Regulatory Compliance requirements.
Marketing authorization holders may be required to submit updated Quality Documentation, manufacturing and licensing details, certificates, and other supporting evidence demonstrating ongoing compliance with applicable Licensing Requirements. This Product Lifecycle Management process enables continued regulatory oversight while ensuring the legal availability of veterinary medicinal products in the Malaysian market.
The publication further reinforces NPRA’s commitment to maintaining high standards for veterinary healthcare products through effective regulatory review and monitoring under the NPRA Malaysia framework.
Select Mandate HA
Select Mandate Function